Federal award
ADAMAS PHARMACEUTICALS, INC.
W911QY10C0193
Contract
Obligated and Ceiling
- Obligated (net)
- $392,277.15
- Ceiling (potential value, not spending)
- $392,277.15
- Current value
- $392,277.15
- Gross positive obligations
- $396,665.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ADAMAS PHARMACEUTICALS, INC. · PBKZPNYNBLU5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ADAMAS PHARMACEUTICALS, INC. · PBKZPNYNBLU5
- Awarding agency
- Department of War · sub-agency 2100 · office W911QY
- Funding agency
- Department of War · sub-agency 1700
- Product or service (PSC)
- AN93 · R&D- MEDICAL: OTHER (ADVANCED DEVELOPMENT)
- Industry (NAICS)
- 541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
- PIID
- W911QY10C0193
- Award type code
- D
- Actions
- 4 · Sep 28, 2010 to May 10, 2013
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 10, 2013 | FY2013 | P00003 | M | −$4,387.85 | — |
| Apr 1, 2011 | FY2011 | P00002 | M | $0.00 | — |
| Oct 19, 2010 | FY2011 | P00001 | M | $0.00 | — |
| Sep 28, 2010 | FY2010 | 0 | — | $396,665.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.